M C Fisher
Overview
Explore the profile of M C Fisher including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
75
Citations
1478
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
de Carvalho J, Beale M, Hagen F, Fisher M, Kano R, Bonifaz A, et al.
Stud Mycol
. 2022 Jan;
100:100129.
PMID: 35027980
() comprises species that are pathogenic to humans and other mammals as well as environmental fungi. Developments in molecular phylogeny have changed our perceptions about the epidemiology, host-association, and virulence...
2.
LaFave S, Suen J, Seau Q, Bergman A, Fisher M, Thorpe Jr R, et al.
J Urban Health
. 2022 Jan;
99(1):28-54.
PMID: 34997433
We reviewed research that examines racism as an independent variable and one or more health outcomes as dependent variables in Black American adults aged 50 years and older in the...
3.
Roberto T, de Carvalho J, Beale M, Hagen F, Fisher M, Hahn R, et al.
Stud Mycol
. 2021 Dec;
100:100131.
PMID: 34934463
Paracoccidioidomycosis (PCM) is a life-threatening systemic fungal infection acquired after inhalation of propagules from the environment. The main agents include members of the complex (phylogenetically-defined species S1, PS2, PS3, and...
4.
Paolo M, Hewitt L, Nwankwo E, Ni M, Vidal-Diaz A, Fisher M, et al.
JAC Antimicrob Resist
. 2021 Jul;
3(3):dlab086.
PMID: 34263165
[This corrects the article DOI: 10.1093/jacamr/dlab026.].
5.
Paolo M, Hewitt L, Nwanko E, Ni M, Vidal-Diaz A, Fisher M, et al.
JAC Antimicrob Resist
. 2021 Jul;
3(1):dlab026.
PMID: 34223100
Background: Individuals with cystic fibrosis (CF) have an increased susceptibility to fungal infection/allergy, with triazoles often used as first-line therapy. Therapeutic drug monitoring (TDM) is essential due to significant pharmacokinetic...
6.
Rodrigues A, Beale M, Hagen F, Fisher M, Terra P, de Hoog S, et al.
Stud Mycol
. 2020 Dec;
97:100095.
PMID: 33335607
Histoplasmosis is a serious infectious disease in humans caused by spp. (Onygenales), whose natural reservoirs are thought to be soil enriched with bird and bat guano. The true global burden...
7.
Valenzuela-Sanchez A, OHanlon S, Alvarado-Rybak M, Uribe-Rivera D, Cunningham A, Fisher M, et al.
Transbound Emerg Dis
. 2017 Dec;
65(2):309-314.
PMID: 29205924
Emerging fungal diseases represent a threat to food security, animal and human health worldwide. Amphibian chytridiomycosis, caused by the fungus Batrachochytrium dendrobatidis (Bd), has been associated with catastrophic and well-documented...
8.
Martel A, Blooi M, Adriaensen C, Van Rooij P, Beukema W, Fisher M, et al.
Science
. 2014 Nov;
346(6209):630-1.
PMID: 25359973
Emerging infectious diseases are reducing biodiversity on a global scale. Recently, the emergence of the chytrid fungus Batrachochytrium salamandrivorans resulted in rapid declines in populations of European fire salamanders. Here,...
9.
Henk D, Eagle C, Brown K, van den Berg M, Dyer P, Peterson S, et al.
Mol Ecol
. 2011 Sep;
20(20):4288-301.
PMID: 21951491
Eighty years ago, Alexander Fleming described the antibiotic effects of a fungus that had contaminated his bacterial culture, kick starting the antimicrobial revolution. The fungus was later ascribed to a...
10.
Fisher M, Koenig G, White T, Taylor J
Mycologia
. 2010 Dec;
94(1):73-84.
PMID: 21156479
Coccidioides posadasii sp. nov., formerly known as non-California (non-CA) Coccidioides immitis, is described. Phylogenetic analyses using single nucleotide polymorphisms, genes, and microsatellites show that C. posadasii represents a divergent, genetically...